Fox Business: Interview with CEO Michael Heltzen
heltzeninvestorpress clippingsvideo
Fox Business: Interview with CEO Michael HeltzenMarch 3, 2025
Edgardo Rayo, new member of the Board of Directors at eXoZymes Inc.
press releaseinvestor
eXoZymes and MDB Capital Announce Leadership Transition at eXoZymes Inc.February 21, 2025
Watch eXoZymes' Nasdaq closing bell ceremony
heltzeninvestorvideo
Watch eXoZymes' Nasdaq closing bell ceremonyFebruary 20, 2025
eXoZymes Announces Nasdaq Bell Ringing to Commemorate Initial Public Offering on Feb 19, 2025
press releaseIPOinvestor
Nasdaq Bell Ringing to Commemorate Initial Public OfferingFebruary 19, 2025
GEN Edge: What’s in a Name - Out with Invizyne, In with eXoZymes
press clippings
GEN Edge: What’s in a Name - Out with Invizyne, In with eXoZymesFebruary 15, 2025
Creating value for partners through exozyme biosolutions
investorvideo
Creating value for partners through exozyme biosolutionsFebruary 12, 2025
The difference between enzymes and exozymes: Explaining our tech
investorvideo
The difference between enzymes and exozymes: Explaining our techFebruary 12, 2025
Vision: What's the potential impact of exozymes?
investorvideo
Vision: What's the potential impact of exozymes?February 12, 2025
eXoZymes signifiy a sustainable paradigm shift in chemical production leveraging AI-engineered enzymes
investorvideo
eXoZymes signifiy a sustainable paradigm shift in chemical production leveraging AI-engineered enzymesFebruary 12, 2025
Rebranding Invizyne to eXoZymes signifies a sustainable paradigm shift in chemical production leveraging AI-engineered enzymes
press releaseinvestor
Rebranding Invizyne to eXoZymes signifies a sustainable paradigm shift in chemical production leveraging AI-engineered enzymesFebruary 12, 2025
Previous page
Page 7 of 11
Next page